Dual-Modal Near-Infrared Organic Nanoparticles: Integrating Mild Hyperthermia Phototherapy with Fluorescence Imaging
Raluca Borlan,Madalina Tudor,Olga Soritau,Adrian Florea,Emoke Pall,Bogdan Pop,Dana Maniu,Simion Astilean,Monica Focsan
DOI: https://doi.org/10.2147/ijn.s472882
IF: 7.033
2024-09-05
International Journal of Nanomedicine
Abstract:Raluca Borlan, 1, &ast Madalina Tudor, 1, 2, &ast Olga Soritau, 3 Adrian Florea, 4 Emoke Pall, 5 Bogdan Pop, 6, 7 Dana Maniu, 2 Simion Astilean, 1, 2 Monica Focsan 1, 2 1 Nanobiophotonics and Laser Microspectroscopy Centre, Interdisciplinary Research Institute on Bio-Nano-Sciences, Babes-Bolyai University, Cluj-Napoca, Cluj, Romania; 2 Biomolecular Physics Department, Faculty of Physics, Babes-Bolyai University, Cluj-Napoca, Cluj, Romania; 3 Department of Radiobiology and Tumor Biology, Oncology Institute Prof. Dr. Ion Chiricuta, Cluj-Napoca, Cluj, Romania; 4 Department of Cell and Molecular Biology, Faculty of Medicine, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Cluj, Romania; 5 Department of Infectious Diseases, University of Agricultural Sciences and Veterinary Medicine, Cluj-Napoca, Cluj, Romania; 6 Department of Pathology, Oncology Institute Prof. Dr. Ion Chiricuta, Cluj-Napoca, Cluj, Romania; 7 Department of Pathology, University of Medicine and Pharmacy Iuliu Hatieganu, Cluj-Napoca, Cluj, Romania &astThese authors contributed equally to this work Correspondence: Monica Focsan, Biomolecular Physics Department, Faculty of Physics, Babes-Bolyai University; Nanobiophotonics and Laser Microspectroscopy Centre, Interdisciplinary Research Institute on Bio-Nano-Sciences, Str. Treboniu Laurian 42, Cluj-Napoca, 400271, Romania, Email Purpose: Our study seeks to develop dual-modal organic-nanoagents for cancer therapy and real-time fluorescence imaging, followed by their pre-clinical evaluation on a murine model. Integrating NIR molecular imaging with nanotechnology, our aim is to improve outcomes for early-stage cutaneous melanoma by offering more effective and less invasive methods. This approach has the potential to enhance both photothermal therapy (PTT) and Sentinel Lymph Node Biopsy (SLNB) procedures for melanoma patients. Methods: NIR-797-isothiocyanate was encapsulated in poly(D,L-lactide-co-glycolide) acid (PLGA) nanoparticles (NPs) using a two-step protocol, followed by thorough characterization, including assessing loading efficiency, fluorescence stability, and photothermal conversion. Biocompatibility and cellular uptake were tested in vitro on melanoma cells, while PTT assay, with real-time thermal monitoring, was performed in vivo on tumor-bearing mice under irradiation with an 808 nm laser. Finally, ex vivo fluorescence microscopy, histopathological assay, and TEM imaging were performed. Results: Our PLGA NPs, with a diameter of 270 nm, negative charge, and 60% NIR-797 loading efficiency, demonstrated excellent stability and fluorescence properties, as well as efficient light-to-heat conversion. In vitro studies confirmed their biocompatibility and cellular internalization. In vivo experiments demonstrated their efficacy as photothermal agents, inducing mild hyperthermia with temperatures reaching up to 43.8 °C. Ex vivo microscopy of tumor tissue confirmed persistent NIR fluorescence and uniform distribution of the NPs. Histopathological and TEM assays revealed early apoptosis, immune cell response, ultrastructural damage, and intracellular material debris resulting from combined NP treatment and irradiation. Additionally, TEM analyses of irradiated zone margins showed attenuated cellular damage, highlighting the precision and effectiveness of our targeted treatment approach. Conclusion: Specifically tailored for dual-modal NIR functionality, our NPs offer a novel approach in cancer PTT and real-time fluorescence monitoring, signaling a promising avenue toward clinical translation. Keywords: organic nanoparticles, dual-modal agents, NIR fluorescence imaging, NIR phototherapeutic agents, mild hyperthermia, melanoma Graphical On a global scale, it is envisaged that the incidence of new cancer cases shall witness an impressive surge to approximately 47% by the year 2040. This projection primarily arises from population growth and the aging demographic, with potential aggravation stemming from the escalating prevalence of risk factors across various regions. Implementing primary prevention strategies emerges as a particularly effective approach in cancer control, given that approximately half of all cancer cases are preventable. 1 For instance, the mortality rate of melanoma, a deadly variant of skin cancer, has become a topic of paramount concern in recent years. Melanoma prevention, consisting of minimizing exposure to known risk factors, such as ultraviolet radiation from sunlight or tanning beds, plays a crucial role in m -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology